Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An 8-Week, Multicenter, Randomized, Double-blind, Four-arm, Parallel-group Study Comparing the Safety and Efficacy of ABT-143 to Simvastatin in Subjects With Hypercholesterolemia

NCT00812955 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00812955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00812955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An 8-Week, Multicenter, Randomized, Double-blind, Four-arm, Parallel-group Study Comparing the Safety and Efficacy of ABT-143 to Simvastatin in Subjects With Hypercholesterolemia
Lead sponsor
AstraZeneca
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2008
Completion date
June 30, 2009
Enrollment
474 (actual)
Sites
129

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemia, hypercholesterolemia, hypertriglyceridemia